It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...

Having counseled thousands of patients through their breast cancer diagnosis, I was fully aware of how nondiscriminatory this ...

Dr. Maxwell Lloyd discusses the long-term management of patients with HR-positive, HER2-negative breast cancer who have received Orserdu treatment.

Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.

PANAMA CITY BEACH, Fla. (WJHG/WECP) - The annual Fore Her Pink Run and Walk is coming up next month. Funds raised from the event will help breast cancer patients in the Panhandle. It will be held on ...

Low-dose oral minoxidil, the hair growth drug which is the active ingredient in Rogaine, may be safe and effective for ...

Questions about sex and intimacy often go unanswered for people with cancer. It's a glaring problem, especially for the ...

It’s been months in the making, but now the new resource is available for those battling the treatable, but incurable form of ...

A new study that provides estimates of people living with metastatic breast cancer, also known as secondary breast cancer, ...

Several major drugmakers have restricted commercially insured patients from their patient assistance programs, leaving ...

A new analysis of the Breast Cancer Index (BCI) may help identify women with HR-positive breast cancer who could potentially ...

Drugmaker Daiichi Sankyo has risen the most in five months after its novel breast cancer treatment won U.S. approval, a ...